115 related articles for article (PubMed ID: 3315337)
1. Isotype and cytotoxicity spectra of anti-lymphocyte antibodies in patients with systemic lupus erythematosus.
Edwards BS; Searles RP; Brozek CM; Richards R; Savage SM; Nolla H; Hoffman CL
Clin Immunol Immunopathol; 1987 Dec; 45(3):333-47. PubMed ID: 3315337
[TBL] [Abstract][Full Text] [Related]
2. T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.
Okudaira K; Searles RP; Tanimoto K; Horiuchi Y; Williams RC
J Clin Invest; 1982 Apr; 69(4):1026-38. PubMed ID: 6978891
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte destruction by antibody-dependent cellular cytotoxicity mediated in vitro by antibodies in serum from patients with systemic lupus erythematosus.
Mahowald ML; Dalmasso AP
Ann Rheum Dis; 1982 Dec; 41(6):593-8. PubMed ID: 7149796
[TBL] [Abstract][Full Text] [Related]
4. Anti-lymphocyte antibodies in systemic lupus erythematosus.
Winfield JB
Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
[TBL] [Abstract][Full Text] [Related]
5. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
[TBL] [Abstract][Full Text] [Related]
6. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products.
Litvin DA; Cohen PL; Winfield JB
J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
Kumagai S; Steinberg AD; Green I
J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750
[TBL] [Abstract][Full Text] [Related]
8. Differential isotype expression and binding properties of T cell-reactive antibodies in human immunodeficiency virus (HIV) infection.
Silvestris F; Azzolini C; Dammacco F
J Clin Immunol; 1992 Mar; 12(2):107-15. PubMed ID: 1373149
[TBL] [Abstract][Full Text] [Related]
9. Monocyte (macrophage)-specific antibodies in patients with systemic lupus erythematosus (SLE).
Shirakawa F; Yamashita U; Suzuki H
J Clin Immunol; 1987 Mar; 7(2):121-9. PubMed ID: 3571434
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein specificity of cold-reactive IgM antilymphocyte autoantibodies in systemic lupus erythematosus.
Mimura T; Fernsten P; Shaw M; Jarjour W; Winfield JB
Arthritis Rheum; 1990 Aug; 33(8):1226-32. PubMed ID: 2202314
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
[TBL] [Abstract][Full Text] [Related]
12. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
[TBL] [Abstract][Full Text] [Related]
13. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of antilymphocyte antibody in SLE and its correlation with disease activity.
Okudaira K; Tanimoto K; Aikawa T; Horiuchi Y; Aotsuka S
Scand J Rheumatol; 1983; 12(1):21-8. PubMed ID: 6601298
[TBL] [Abstract][Full Text] [Related]
15. Effects of immunoglobulin G from patients with systemic lupus erythematosus on human B cell function.
Ramirez F; Searles RP; Williams RC
Clin Immunol Immunopathol; 1987 Aug; 44(2):219-34. PubMed ID: 3111767
[TBL] [Abstract][Full Text] [Related]
16. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
Pradhan V; Pandit P; Rajadhyaksha A; Patwardhan M; Surve P; Kamble P; Lecerf M; Bayry J; Kaveri S; Ghosh K; Nadkar MY
J Assoc Physicians India; 2016 May; 64(5):14-18. PubMed ID: 27735143
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus sera inhibit antigen presentation by macrophages to T cells.
Brozek CM; Hoffman CL; Savage SM; Searles RP
Clin Immunol Immunopathol; 1988 Feb; 46(2):299-313. PubMed ID: 3257427
[TBL] [Abstract][Full Text] [Related]
18. Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus.
Winfield JB; Winchester RJ; Wernet P; Fu SM; Kunkel HG
Arthritis Rheum; 1975; 18(1):1-8. PubMed ID: 46753
[TBL] [Abstract][Full Text] [Related]
19. Naturally occurring anti-idiotypic antibodies reactive with anti-DNA antibodies in systemic lupus erythematosus.
Williams WM; Isenberg DA
Lupus; 1998; 7(3):164-75. PubMed ID: 9607640
[TBL] [Abstract][Full Text] [Related]
20. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus.
Winfield JB; Shaw M; Minota S
J Immunol; 1986 May; 136(9):3246-53. PubMed ID: 3007614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
